financetom
Business
financetom
/
Business
/
Hemlo Explorers at a 52-Week High as it Boosts a Private Placement to $2 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hemlo Explorers at a 52-Week High as it Boosts a Private Placement to $2 Million
Oct 11, 2024 11:18 AM

02:04 PM EDT, 10/11/2024 (MT Newswires) -- Hemlo Explorers ( CNOBF ) on Friday upsized its non-brokered private placement by $500,000, to $2 million.

The company will now sell 40-million share units at $0.05 each and flow-through shares, also at $0.05 each.

Proceeds from the flow-through shares will be used for the exploration and advancement of Hemlo's Newfoundland projects, while proceeds of the units will be used for general corporate purposes.

Hemlo shares were last seen up $0.02, or 29%, to a 52-week high of $0.09 on the Canadian Securities Exchange

Price: 0.09, Change: +0.02, Percent Change: +28.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canadian Solar's e-Storage Lands Contract to Develop Energy Storage Facilities in Nova Scotia
Canadian Solar's e-Storage Lands Contract to Develop Energy Storage Facilities in Nova Scotia
Jul 8, 2024
08:12 AM EDT, 07/08/2024 (MT Newswires) -- Canadian Solar ( CSIQ ) said Monday that its CSI Solar unit's e-Storage business has secured a contract from a Nova Scotia Power to develop three energy storage projects across the Atlantic Canadian province. Canadian Solar ( CSIQ ) said that the projects, totaling 150 megawatts, will be built in Bridgewater, Waverley and...
BRIEF-Ligand To Acquire Apeiron Biologics AG For $100 Million
BRIEF-Ligand To Acquire Apeiron Biologics AG For $100 Million
Jul 8, 2024
July 8 (Reuters) - Ligand Pharmaceuticals Inc ( LGND ): * LIGAND TO ACQUIRE APEIRON BIOLOGICS AG FOR $100 MILLION * LIGAND PHARMACEUTICALS INC ( LGND ) - LIGAND INCREASES 2024 ADJUSTED EPS GUIDANCE RANGE BY 17% TO $5.00-$5.50 * LIGAND PHARMACEUTICALS ( LGND )- DEAL TO BE IMMEDIATELY ACCRETIVE TO LIGAND EPS BY ESTIMATED $1.00 PER SHARE ON AN...
Ligand to Acquire Apeiron for $100 Million in Cash, Plus Up to $28 Million Based on Royalties
Ligand to Acquire Apeiron for $100 Million in Cash, Plus Up to $28 Million Based on Royalties
Jul 8, 2024
08:09 AM EDT, 07/08/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) said Monday it has agreed to acquire Apeiron Biologics for $100 million in cash and up to $28 million based on future royalty payments. Austria-based Aperion holds the royalty rights to Qarziba, a treatment for high-risk neuroblastoma commercialized in more than 35 countries. Additional royalty payments to Apeiron...
BRIEF-Montrose Environmental Group Acquires Spirit Environmental, Expanding Air Consulting Capabilities Across The Central United States
BRIEF-Montrose Environmental Group Acquires Spirit Environmental, Expanding Air Consulting Capabilities Across The Central United States
Jul 8, 2024
July 8 (Reuters) - Montrose Environmental Group Inc ( MEG ) : * MONTROSE ENVIRONMENTAL GROUP ACQUIRES SPIRIT ENVIRONMENTAL, EXPANDING AIR CONSULTING CAPABILITIES ACROSS THE CENTRAL UNITED STATES * MONTROSE ENVIRONMENTAL GROUP INC ( MEG ) - TERMS OF TRANSACTION WERE NOT DISCLOSED Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved